Charles Bancroft has been appointed chief financial officer of Bristol-Myers Squibb. Mr. Bancroft will be responsible for directing and managing the company’s fiscal operations and the global finance organization. He has been serving as acting chief financial officer since January 1, 2010. He will report to Lamberto Andreotti, president and chief operating officer, and chief executive officer designate.
“The board of directors, Jim Cornelius and I have great confidence in Charlie’s ability to provide the financial stewardship needed to help drive shareholder value,” said Mr. Andreotti. “His tenure with Bristol-Myers Squibb has been marked by strong leadership and depth of experience in finance, earning him trust and respect from his peers across all functions and within the entire finance organization.”
Mr. Bancroft joined the company in 1984 and has held positions of increasing responsibility within finance, including international assignments, and senior leadership positions in the global pharmaceutical business.